Astera Labs (NASDAQ:ALAB) Stock Price Up 11.1% – Here’s What Happened

Astera Labs, Inc. (NASDAQ:ALAB) shares rose 11.1% on Thursday . The company traded as high as $367.88 and last traded at $367.47. Approximately 5,666,583 shares were traded during trading, an increase of 2% from the average daily volume of 5,563,224 shares. The stock had previously closed at $330.86.

Analysts Set New Price Targets

ALAB has been the topic of a number of recent analyst reports. Jefferies Financial Group reaffirmed a “buy” rating and set a $270.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Loop Capital initiated coverage on Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target on the stock. JPMorgan Chase & Co. lifted their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Northland Securities cut Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Finally, Barclays lifted their price target on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Price Performance

The stock has a market cap of $62.93 billion, a P/E ratio of 248.07, a PEG ratio of 4.87 and a beta of 3.95. The company has a fifty day moving average of $237.17 and a 200 day moving average of $178.94.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the previous year, the company earned $0.33 earnings per share. The firm’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Activity

In related news, General Counsel Philip Mazzara sold 796 shares of the business’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $291.03, for a total transaction of $231,659.88. Following the sale, the general counsel owned 103,343 shares of the company’s stock, valued at $30,075,913.29. The trade was a 0.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director directly owned 75,688 shares in the company, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,321,256 shares of company stock valued at $480,893,146 over the last 90 days. Corporate insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Shariaportfolio Inc. bought a new stake in Astera Labs during the first quarter worth approximately $5,304,000. Glenmede Trust Co. NA grew its position in Astera Labs by 2.7% in the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after buying an additional 51 shares during the last quarter. Verus Capital Partners LLC grew its position in Astera Labs by 16.4% in the first quarter. Verus Capital Partners LLC now owns 3,849 shares of the company’s stock worth $422,000 after buying an additional 541 shares during the last quarter. Liontrust Investment Partners LLP grew its position in Astera Labs by 98.7% in the first quarter. Liontrust Investment Partners LLP now owns 105,270 shares of the company’s stock worth $11,538,000 after buying an additional 52,284 shares during the last quarter. Finally, SOA Wealth Advisors LLC. acquired a new position in Astera Labs in the first quarter worth approximately $49,000. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.